Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China

Arthritis and Rheumatism

Volumn 63, Issue 5, 2011, Pages 1182-1189

  Mok, C C ^a   Kwok, C L ^b   Ho, L Y ^a   Chan, P T ^a   Yip, S F ^b  

^a TUEN MUN HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHINA; DISEASE ACTIVITY; FEMALE; GASTROINTESTINAL DISEASE; HONG KONG; HUMAN; INFECTION; INJURY; INTOXICATION; KIDNEY FAILURE; LIFE EXPECTANCY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RESPIRATORY TRACT DISEASE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTEMIC VASCULITIS;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; FEMALE; HONG KONG; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; RHEUMATIC DISEASES; SEX FACTORS;

EID: 79955563440     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30277     Document Type: Article

References (39)

1. Dessein PH, Joffe BI, Singh S,. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 2005; 7: R634-43.
2. Rho YH, Chung CP, Oeser A, Solus J, Asanuma Y, Sokka T, et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2009; 61: 1580-5.
3. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Pineiro A, Garcia-Porrua C, Miranda-Filloy JA, et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007; 57: 125-32.
4. Meune C, Touze E, Trinquart L, Allanore Y,. High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis 2010; 103: 253-61.
5. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV,. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006; 33: 2167-72. (Pubitemid 44749774)
6. Mok CC, Ho LY, To CH,. Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus. Scand J Rheumatol 2009; 38: 362-8.
7. Gladman DD, Ang M, Su L, Tom BD, Schentag CT, Farewell VT,. Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 2009; 68: 1131-5.
8. Mok CC, Mak A, Chu WP, To CH, Wong SN,. Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore) 2005; 84: 218-24. (Pubitemid 41026296)
9. Mok CC, To CH, Ho LY, Yu KL,. Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006. J Rheumatol 2008; 35: 1978-82.
10. Andersen PK, Borgan O, Gill RD, Keiding N,. Statistical models based on counting processes. New York: Springer-Verlag; 1993. p. 322.
11. Preston SH, Heuveline P, Guillot M,. Demography: measuring and modeling population processes. Oxford (UK): Blackwell; 2009. p. 38-70.
12. Agresti A,. Categorical data analysis. New York: John Wiley & Sons; 1990. p. 40.
13. Hersh AO, Trupin L, Yazdany J, Panopalis P, Julian L, Katz P, et al. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010; 62: 1152-9.
14. Urowitz MB, Gladman DD, Tom BD, Ibanez D, Farewell VT,. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 2008; 35: 2152-8.
15. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2550-7. (Pubitemid 44205016)
16. Chun BC, Bae SC,. Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang lupus cohort in Seoul, Korea. Lupus 2005; 14: 635-8.
17. Bjornadal L, Yin L, Granath F, Klareskog L, Ekbom A,. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. J Rheumatol 2004; 31: 713-9. (Pubitemid 38451257)
18. Nakajima A, Inoue E, Tanaka E, Singh G, Sato E, Hoshi D, et al. Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol 2010; 39: 360-7.
19. Bergstrom U, Jacobsson LT, Turesson C,. Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmö, Sweden. Rheumatology (Oxford) 2009; 48: 1600-5.
20. Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S, et al. Early Rheumatoid Arthritis Study (ERAS) group. Mortality in rheumatoid arthritis: increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford) 2007; 46: 350-7. (Pubitemid 46189799)
21. Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM III, Therneau TM, et al. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007; 56: 3583-7. (Pubitemid 350100691)
22. Sihvonen S, Korpela M, Laippala P, Mustonen J, Pasternack A,. Death rates and causes of death in patients with rheumatoid arthritis: a population-based study. Scand J Rheumatol 2004; 33: 221-7. (Pubitemid 39180164)
23. Minaur NJ, Jacoby RK, Cosh JA, Taylor G, Rasker JJ,. Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality. J Rheumatol Suppl 2004; 69: 3-8. (Pubitemid 38327484)
24. Thomas E, Symmons DP, Brewster DH, Black RJ, Macfarlane GJ,. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol 2003; 30: 958-65. (Pubitemid 36529614)
25. Gabriel SE, Crowson CS, Maradit Kremers H, Doran MF, Turesson C, O'Fallon WM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 2003; 48: 54-8. (Pubitemid 36091647)
26. Bjornadal L, Baecklund E, Yin L, Granath F, Klareskog L, Ekbom A,. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. J Rheumatol 2002; 29: 906-12. (Pubitemid 34493491)
27. Gordon P, West J, Jones H, Gibson T,. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96. J Rheumatol 2001; 28: 2409-15. (Pubitemid 33031969)
28. Martinez MS, Garcia-Monforte A, Rivera J,. Survival study of rheumatoid arthritis patients in Madrid (Spain): a 9-year prospective follow-up. Scand J Rheumatol 2001; 30: 195-8. (Pubitemid 32762854)
29. Chehata JC, Hassell AB, Clarke SA, Mattey DL, Jones MA, Jones PW, et al. Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity. Rheumatology (Oxford) 2001; 40: 447-52.
30. Buckley C, Cavill C, Taylor G, Kay H, Waldron N, Korendowych E, et al. Mortality in psoriatic arthritis-a single-center study from the UK. J Rheumatol 2010; 37: 2141-4.
31. Ali Y, Tom BD, Schentag CT, Farewell VT, Gladman DD,. Improved survival in psoriatic arthritis with calendar time. Arthritis Rheum 2007; 56: 2708-14. (Pubitemid 47237289)
32. Wong K, Gladman DD, Husted J, Long JA, Farewell VT,. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997; 40: 1868-72. (Pubitemid 27452539)
33. Hissaria P, Lester S, Hakendorf P, Woodman R, Patterson K, Hill C, et al. Survival in scleroderma: results from the population based south Australian register. Intern Med J 2010. E-pub ahead of print.
34. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005; 118: 2-10. (Pubitemid 40082450)
35. Simeon CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, et al. Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology (Oxford) 2003; 42: 71-5. (Pubitemid 36131570)
36. Eriksson P, Jacobsson L, Lindell A, Nilsson JA, Skogh T,. Improved outcome in Wegener's granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts. J Intern Med 2009; 265: 496-506.
37. Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M,. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 2009; 48: 1560-5.
38. Lane SE, Watts RA, Shepstone L, Scott DG,. Primary systemic vasculitis: clinical features and mortality. QJM 2005; 98: 97-111. (Pubitemid 40277566)
39. Lehtinen K,. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993; 52: 174-6. (Pubitemid 23094303)